Health ❯Healthcare ❯Pharmaceuticals ❯Weight Loss

Semaglutide

UK ‘Postcode Lottery’ for Weight-Loss Jabs Persists as Generics Line Up for 2026

Patchy NHS access meets looming overseas generics, raising price pressure plus safety risks for UK patients.

Triple-Dose Semaglutide Outperforms Standard Regimen in Weight-Loss Trials

Half of Semaglutide Users Quit Within a Year as Higher Dose Trials Show Bigger Losses, More Side Effects

Eli Lilly’s Oral Obesity Pill Triggers Stock Slide After Modest Weight-Loss Results

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

Semaglutide Shows Potential to Slow Aging and Reduce Mortality Rates

Semaglutide Drugs Show Potential Beyond Weight Loss

Surge in GLP-1 Drugs for Weight Loss Sparks Concerns Over Diabetes Treatment

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients